NCT06341712
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06341712
Title Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma (CabOSTar)
Acronym CabOSTar
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ipsen
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | POL | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Children's Hospital of the King's Daughters Norfolk Virginia 23507 United States Details
University Hospital Gent Ghent Belgium Details
McGill University Health Centre - Centre for Innovative Medicine Québec Canada Details
Princess Margaret cancer center Toronto Canada Details
Centre Oscar Lambret Lille France Details
Universitätsmedizin Mainz Mainz Germany Details
Dr. von Haunerschen Kinderspital München Germany Details
Ospedale Ortopedico Rizzoli di Bologna Bologna Italy Details
AOU Città della Salute e della Scienza di Torino Piemonte Italy Details
Amsterdam UMC - Locatie AMC Amsterdam Netherlands Details
Instytut Matki i Dziecka Warsaw Poland Details
Hospital de La Santa Creu i Sant Pau Barcelona Spain Details
Hospital Universitario Vall d'Hebron Barcelona Spain Details
Hospital Infantil Universitario Nino Jesus Madrid Spain Details
Hospital Universitari i Politecnic La Fe Valencia Spain Details
Birmingham Children's Hospital Birmingham United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field